Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Keane

Showing results (441-450 of 497) with videos related to

Pageof 50
Sort By:
Circulation|November 1, 1993
Intraoperative device closure of ventricular septal defectsS B Fishberger, N D Bridges, J F Keane, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The disposition and protein binding of batanopride and its metabolites in subjects with renal impairmentJ V St Peter, M E Brady, E F Foote, et al.
BJU International|May 8, 1999
Apoptosis and its clinical significance for bladder cancer therapyJ D Kelly, K E Williamson, A E Irvine, et al.
Lancet (London, England)|October 21, 1995
Prevention of diabetic renal disease with special reference to microalbuminuriaC E Mogensen, W F Keane, P H Bennett, et al.
The American Journal of Cardiology|December 1, 1988
Echocardiographic and anatomic findings in atrioventricular discordance with ventriculoarterial concordanceL Pasquini, S P Sanders, I Parness, et al.
Circulation|August 11, 2004
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathyDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.
Kidney International|May 20, 2004
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAALDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.
Circulation|February 1, 1993
Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defectsL Kidd, D J Driscoll, W M Gersony, et al.
Circulation|February 1, 1993
Second natural history study of congenital heart defects. Quality of life of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defectW M Gersony, C J Hayes, D J Driscoll, et al.
The New England Journal of Medicine|May 9, 1991
Preoperative transcatheter closure of congenital muscular ventricular septal defectsN D Bridges, S B Perry, J F Keane, et al.
Pageof 50

Showing results (441-450 of 497) with videos related to

Sort By:
Pageof 50
Circulation|November 1, 1993
Intraoperative device closure of ventricular septal defectsS B Fishberger, N D Bridges, J F Keane, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The disposition and protein binding of batanopride and its metabolites in subjects with renal impairmentJ V St Peter, M E Brady, E F Foote, et al.
BJU International|May 8, 1999
Apoptosis and its clinical significance for bladder cancer therapyJ D Kelly, K E Williamson, A E Irvine, et al.
Lancet (London, England)|October 21, 1995
Prevention of diabetic renal disease with special reference to microalbuminuriaC E Mogensen, W F Keane, P H Bennett, et al.
The American Journal of Cardiology|December 1, 1988
Echocardiographic and anatomic findings in atrioventricular discordance with ventriculoarterial concordanceL Pasquini, S P Sanders, I Parness, et al.
Circulation|August 11, 2004
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathyDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.
Kidney International|May 20, 2004
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAALDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.
Circulation|February 1, 1993
Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defectsL Kidd, D J Driscoll, W M Gersony, et al.
Circulation|February 1, 1993
Second natural history study of congenital heart defects. Quality of life of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defectW M Gersony, C J Hayes, D J Driscoll, et al.
The New England Journal of Medicine|May 9, 1991
Preoperative transcatheter closure of congenital muscular ventricular septal defectsN D Bridges, S B Perry, J F Keane, et al.
Pageof 50